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1 Introduction 
Forward patent citations are a ubiquitous indicator of the impact and value of patents and, by extension, 
patent portfolios. Forward citations – i.e. the number of times a patent is deemed relevant prior art by 
the examiners and/or applicants of later patents – have obtained this position in part due to the 
extensive validation of this indicator. Validation efforts progressed from early small-scale studies 
(Carpenter et al. 1981; Trajtenberg, 1991) to larger studies involving large patent sets (e.g. Bessen, 2008;  
Hall et al. 2005; Gambardella et al. 2008). Moreover, patent citations have been found to correspond to 
several constructs of value: innovative value (Albert et al. 1991; Arts et al. 2013; Carpenter et al. 1981; 
Trajtenberg, 1991), private value (Harhoff et al. 1999, 2003; Gambardella et al. 2008) and market value 
(Belenzon, 2012; Hall et al. 2005).    
However, several authors have signaled a disturbing lack of explanatory power when using patent 
citations to explain patent value (e.g. Gay and Le Bas, 2005; Gittelman, 2008). Furthermore, the 
distribution of patent citations is skewed and often involves outliers. Consequently, log-linear 
transformations have been advanced as a solution (e.g. Harhoff et al. 1999; Gambardella et al. 2008). 
Moreover, a non-linear approach may be required because of the specificities of the patent citation 
network. For instance, Hung and Wang (2010) found that patent citations follow a rule of preferential 
attachment. This phenomenon, as first outlined by Barabási and Albert (1991), entails in this case that 
patents more frequently cite patents that have already been cited regardless of quality considerations. 
Therefore, later citations could have a lesser value, thus indicating that patent citations do not scale 
linearly with patent value.  
In most studies that involve patent data, patents statistics are grouped. This can be undertaken on the 
level of a firm’s patent portfolio (e.g. Hall et al. 2005) or on national levels (e.g. Neuhäusler and Frietsch, 
2012). If patent value does not scale linearly with the sum of patent citations on the individual level, this 
would also have implications for the group level. Consequently, patent portfolios would have to be 
calculated differently; simply taking the sum of patent citations to patents in the portfolio would be 
inadequate. 
The continued relevance of patent citations as an important measure of value, as noted in Jaffe and de 
Rassenfosse (2016), increases the importance of better understanding the relation between patent 
citations and patent value. This will help in analyses where patent value is modeled as a dependent 
variable, used as an independent variable, or used as a control. Improvements in using patent citations 
as a proxy for patent value may also benefit research on patent portfolios and, by extension, modeling 
the innovative performance of large actors such as firms and countries. Moreover, it secures a better 
insight into the processes by which patent citations have come to be correlated with patent value. 
In this paper, the relevance of a log-linear relationship is demonstrated by relating patent citations to 
patent renewal data. This is undertaken for patents from both the European Patent Office (EPO) and the 
United States Patent and Trademark Office (USPTO) because they have different renewal characteristics. 
Consequently, comparing the analyses of patents from these offices will provide robustness to the 
results. In a complementary analysis, the derived functional form is assessed by analyzing the value of 
firm portfolios in an adapted replication of Hall et al. (2005). The results reveal a substantial increase in 
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explanatory power that may occur when adopting a model specification that reflects the log-linear 
relationship.  
2 Measuring the relation between citations and renewal 
2.1 Methods and data 
In this analysis, the relationship between patents citations and patent value – as indicated by the 
decision of patent owners to pay maintenance fees, i.e. patent renewal – is assessed. Patent renewal 
can be considered an indicator of private patent value (Pakes and Schankerman, 1984; Pakes, 1984; 
Lanjouw et al. 1998; Harhoff et al. 1999; Thomas, 1999;  Hegde and Sampat, 2009; de Rassenfosse and 
van Pottelsberge de la Potterie, 2013; de Rassenfosse and Jaffe, 2014) since renewal reflects an 
economic decision on the part of the patent owner. In other words, it registers a minimal private value 
that the owner assigns to the patent.  
Patent data is obtained from the European Patent Office (EPO) PATSTAT fall 2013 database and 
complemented with renewal data as observed in fee payments to the relevant patent office from its 
spring 2014 counterpart. The sample was constructed to allow a comparison between EPO and United 
States Patent and Trademark Office (USPTO) patent applications. Therefore, only DOCDB1 patent 
families with granted applications at both the EPO and the USPTO have been included. Using patent 
applications from 1981 to 2000, the sample includes 538,261 granted EPO applications and 563,603 
granted USPTO applications.  To better allow a comparison between results obtained for the EPO 
patents and the USPTO patents, patent citations are observed as citations made to the DOCDB family of 
the patent by other DOCDB patent families. This measure is comparable across patent offices, unlike the 
counts of citations to individual patents of different offices, which are affected by different citation 
practices practiced in different offices and differ considerably (Bakker et al. 2016).   
Observing patent renewal for USPTO patents is relatively easy, as one simply has to observe whether 
maintenance fees have been paid to the USPTO. The USPTO system anticipates three periods of renewal 
with decisions possible at 4, 8 and 12 years of the patent life. The USPTO renewal time is calculated as 
the period for which fees have been paid.  
Observing patent renewal for EPO patents is more complicated because the EPO has no unitary 
structure but acts as an intergovernmental organization operating through member state offices. 
Granted patents are hosted at national offices that subscribe to the EPO (e.g. the Portuguese or the 
Netherlands patent office). Maintenance payments and renewal decisions are also made at these 
offices. Thus, an EPO patent may be renewed at one office but abandoned at another. In order to 
achieve a single EPO renewal indicator, the Single Renewal Approach (SRA) of Van Zeebroeck (2011) is 
used: the EPO renewal indicator is determined by the longest time a patent has been renewed at any of 
the national offices subscribing to the EPO convention. Renewal payments at the national offices that 
                                                          
1 This family groups patents from different offices that have an identical technical content (Albrecht et al. 2010). 
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subscribe to the EPO are made yearly, and EPO renewal time is therefore calculated as the longest 
period for which fees have been paid at any of these national offices.   
An analysis is performed where a dummy is created for each score level of the DOCDB citation indicator. 
Here, the dummies are denoted as 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖, where 𝑖𝑖 denotes the citation score. Levels range from 0, 1, 
2, 3… 99, 100 … 368+. Patents with a score larger than 100 are grouped in progressively larger clusters 
consisting of not one, but several, levels of the citation score. For example, patents with a DOCDB 
citation score of 101, 102 or 103 are grouped in the same cluster. These clusters are treated in the same 
way as individual citation levels, where their citation score is determined by the central value of the 
patent citation score of the levels grouped in each cluster. This procedure is undertaken because the 
density of patents per citation level is otherwise too low for meaningful estimation of the coefficients 
associated with each level. The number of citation levels per cluster is denoted in Table 1. Finally, all 
patents with a score of 368 and above (i.e. 9 standard deviation outliers) are grouped together in one 
category. Because there are few uncited patents, the reference category combines the set of uncited 
patents with the set where patents are cited only once. 
DOCDB citation score Citation levels per cluster 
2-100 1 
101-142 3 
143-178 5 
179-227 7 
228-290 9 
291-367 11 
368+ N/A 
Table 1: Number of citation levels grouped together in each cluster as a function of the DOCDB citation score .  
Including a set of appropriate control variables (𝑥𝑥𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐) and assuming an independent error term 𝜀𝜀, 
the number of years the patent was maintained (𝑡𝑡𝑐𝑐𝑟𝑟𝑐𝑐𝑟𝑟𝑟𝑟𝑟𝑟𝑐𝑐)  can be expressed as a function 𝑓𝑓() of the 
citation levels 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖 and a constant 𝐷𝐷: 
𝑡𝑡𝑐𝑐𝑟𝑟𝑐𝑐𝑟𝑟𝑟𝑟𝑟𝑟𝑐𝑐 = 𝑓𝑓(𝐷𝐷 + �𝛽𝛽𝑖𝑖 ∙ 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖
𝑖𝑖
+ � 𝛽𝛽𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 ∙ 𝑥𝑥𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
) + 𝜀𝜀           
In this model, assuming the function 𝑓𝑓() is correctly chosen to represent the relation between patent 
value and renewal time, the size of the coefficients 𝛽𝛽𝑖𝑖 should relate to 𝑖𝑖 following the functional form 
with which patent citations relate to patent value. 
Pakes (1986) highlighted a real option approach to the estimation of renewal time by considering that 
patent renewal not only extends patent protection for a limited time but also provides the option of 
future extensions. Maurseth (2005) modeled this as a survival problem using a Cox model. This approach 
rests on the idea that an expected revenue stream can be attributed to a patent in each given year. 
Whenever the costs of maintaining the patent (are expected to) exceed the revenue stream, the owner 
of the patent will decide not to continue paying maintenance fees. Because the (modeled) revenue and 
the costs of maintaining a patent are not constant, the relation between patent value and observed 
patent life is not linear. Therefore, a Cox survival analysis should better model patent value through 
patent renewal than a linear regression model such as OLS. The survival model can also take into 
account the censoring that stems from either the data that is absent due to missing renewal information 
at the end of the dataset or from the maximum patent lifetime of 20 years.  
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Cox survival regressions are dependent on the number of distinct possible survival times that can be 
observed. Multiple objects with the same survival time need to be taken into consideration and a 
method needs to be employed to resolve these ties. This is especially important for USPTO cases where 
only three renewal decisions are taken for each patent, resulting in many patents with the exact same 
survival time. In analyses with many ties, the standard method of resolving them (Breslow, 1974) could 
yield biased coefficients while the Efron(1974) method has been advocated as an unbiased method 
(Hertz-Picciotto and Rockhill, 1997; Hsieh, 1995).  Therefore, the analyses have been computed using 
both methods. Small differences were found, but these were not significant in estimating the log-linear 
fits presented in the results section. In the main analyses, the results of Efron’s method are reported 
since they appear to be less biased than those of Breslow’s method (Hertz-Picciotto and Rockhill, 1997).  
This paper attempts to construct a framework that applies to all patents. The analysis, therefore, 
includes control variables concerning the year and the technological class (IPC3 level) of the application, 
because of the likelihood that these variables affect patent citations as well as renewal probability. 
Furthermore, it is likely that different applicants have different renewal considerations and write 
different patents, resulting in different citation characteristics. Thus, the analysis also includes controls 
that reflect basic characteristics (i.e. type, experience, size and country2) of the applicant. This 
information has been obtained from the harmonized table provided for the EPO PATSTAT database 
(Magerman et al. 2006; Peeters et al. 2010). Table 2 provides an overview of the definitions and 
descriptive statistics of the variables used in the analysis.  
Name Description Mean Standard  
deviation 
Min Max 
USPTO renewal 
time Maximum year for which maintenance fees are paid at the USPTO. 14.59 5.76 4 20 
EPO renewal time Maximum year for which maintenance fees are paid at any national office 
subscribing to the EPO. 13.12 4.81 2 20 
DOCDBia Dummy indicating whether the DOCDB patent family of the patent is cited 𝑖𝑖 
times by other DOCDB families. 22.16 39.02 0.00 3146 
Application yeara Dummy for the application year of the patent. 1992.59 5.38 1981 2000 
IPC3b  Dummy variable to indicate if the IPC3 class (e.g. A01) is present in the patent 
application. N/A N/A N/A N/A 
Applicant 
experiencec 
Years between filing of current patent and that of the first application filed by 
the applicant. 36.23 31.12 0 146 
Ln(Applt. size)c  Logarithm of the total number of patents filed by the applicant. 7.40 3.32 0 12.99 
Co-patented Dummy indicating if the patent has more than 1 applicant. 0.06 0.24 0 1 
Applicant typeb Type of applicant: company, government, hospital, individual, university or 
unknown. N/A N/A N/A N/A 
Applicant 
countryb 
Dummy for the country in which the applicant resided at time of filing the 
patent. N/A N/A N/A N/A 
Table 2: descriptions and descriptive statistics of USPTO patents in the Cox survival analyses, statistics for EPO patents deviate slightly and are 
given for EPO renewal. a In the case of dummy variables relating to levels of a discrete variable, statistics are given for this variable. b indicates 
partial counts when applicable. Finally, when an application is co-patented, variables with c default to the largest and oldest applicants. 
2.2 Results 
The coefficient estimates (𝛽𝛽𝑖𝑖) for the 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖 dummies from the Cox survival regression for the USPTO 
renewal data are shown in Figure 1. Note that Cox survival regressions estimate hazard (i.e. abandoning 
                                                          
2 Applicants may come from countries with few patents, which would disrupt the analysis because the dummy 
variable relating to that country cannot be estimated (well). Therefore, applicant countries with less than 50 
patents in the analyses have been grouped together in a separate category. This has affected 819 patents in total. 
6 
 
patents); hence, negative coefficients indicate a higher chance of renewal. The coefficients of the 
analysis are monotonically decreasing, even though, at higher citation levels, there is greater variance in 
this relation. 
A log-linear function of the form 𝛽𝛽𝑖𝑖 = 𝑎𝑎 + 𝑏𝑏 ln(𝑐𝑐 + 𝑖𝑖) is estimated with 𝛽𝛽𝑖𝑖 the size of the dummy 
coefficient and 𝑖𝑖 the citation score.  The log-linear relation depicted fits the relation between the 
citation scores and the coefficients well (R2=0.86).  As a comparison, a  linear curve of the form 𝛽𝛽𝑖𝑖 = 𝑎𝑎 +
𝑏𝑏𝑖𝑖 has also been estimated, which produces a worse fit (R2=0.54). Finally, it can be argued that the log-
linear fit has one more parameter and would, therefore, have an advantage over the linear estimation. 
Consequently, a quadratic curve of the form 𝛽𝛽𝑖𝑖 = 𝑎𝑎 + 𝑏𝑏𝑖𝑖 + 𝑐𝑐𝑖𝑖2 has been estimated as well, and it is a 
better fit than the linear specification  (R2=0.76). Nevertheless, the log-linear specification is a superior 
fit to this specification, indicating that the data fit better with a log-linear form than a polynomial with 
the same number of parameters.    
 
Figure 1: Estimates of the dummy coefficients related to different DOCDB citation scores that were obtained from a Cox survival analysis relating 
different scores on the DOCDB citation indicator to the maintenance time of a patent at the USPTO. A 95% confidence interval is shown as well 
as a log-linear fit of 𝛽𝛽𝑖𝑖 = 0.33 − 0.32 ln(1.43 + 𝑖𝑖), which has an R2 of 0.86. 
Similar results are found when repeating the analysis with EPO data; see Figure 2. Here, the fit is even 
better with R2=0.93 for the log-linear specification. However, the fits for the other curves also improve 
with R2=0.88 for a quadratic curve and R2=0.78 for a linear curve. Therefore, the found log-linear form 
appears to be robust with respect to the source of renewal data. Unfortunately, the analysis does not 
provide a guideline on the optimal offset, given that this parameter varies substantially with a value of 
1.43 for the USPTO analysis and a value of 10.80 for the EPO analysis. 
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Figure 2: Estimates of the dummy coefficients related to different DOCDB citation scores that were obtained from a Cox survival analysis relating 
different scores on the DOCDB citation indicator to the maintenance time of a patent at the EPO. A 95% confidence interval is shown as well as a 
log-linear fit of 𝛽𝛽𝑖𝑖 = 1.27 − 0.55 ln(10.80 + 𝑖𝑖), which has an R2 of 0.93. 
2.3 Robustness 
In this paper, the functional form is estimated using Cox survival analyses. Unfortunately, these analyses 
rely on the proportional hazards assumption. This assumption states that the hazard function only 
differs by a constant non-time dependent value between the observed categories. This assumption can 
be verified by using Schoenfeld (1982) residuals and is violated severely (at p<0.0001) for both the 
USPTO and the EPO analyses.  
In consequence, robustness tests using other model specifications have been performed. First, the 
binary approach from Hegde and Sampat (2009) is adopted, which determines the odds that a patent is 
renewed by a certain time. This approach has the benefit that it relies on few assumptions concerning 
the value function of the patent over time. Unfortunately, it also exploits less of the information 
contained in the renewal data by only observing the patent renewal time at one single time period. In 
this paper, a binary test is employed where the chance that a patent was renewed until it reached its 
maximum lifespan (20 years) is estimated using an adaption of equation (1) as shown below.    
𝑃𝑃(𝑡𝑡𝑐𝑐𝑟𝑟𝑐𝑐𝑟𝑟𝑟𝑟𝑟𝑟𝑐𝑐 = 20) = 𝑃𝑃�𝜀𝜀 > 𝐷𝐷 −�𝛽𝛽𝑖𝑖 ∙ 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖
𝑖𝑖
− � 𝛽𝛽𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 ∙ 𝑥𝑥𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
�   
If 𝜀𝜀 follows a logistic distribution, the 𝛽𝛽𝑖𝑖 coefficients can be estimated using a logistic regression. 
Because this test relies on patents reaching their maximum lifetime, the sample is confined to patents 
that have the possibility of reaching it. At the USPTO, where full renewal is decided at 12 years, this 
includes patents with at least 13 years in the renewal data of spring 2014, which applies to all patents in 
the original sample. For EPO patents, the renewal decisions are taken yearly; hence, only patents with 
application years up to 1993 are included in the logistic analysis.  
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A linear regression analysis is also employed. Here, instead of estimating whether a patent is renewed at 
a certain point in time, its renewal time 𝑡𝑡𝑐𝑐𝑟𝑟𝑐𝑐𝑟𝑟𝑟𝑟𝑟𝑟𝑐𝑐 is directly estimated.  This estimation can be 
constructed easily from equation (1), when assuming function 𝑓𝑓() is linear, leading to the equation 
listed below. 
𝑡𝑡𝑐𝑐𝑟𝑟𝑐𝑐𝑟𝑟𝑟𝑟𝑟𝑟𝑐𝑐 = 𝐷𝐷 + �𝛽𝛽𝑖𝑖 ∙ 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖
𝑖𝑖
+ � 𝛽𝛽𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 ∙ 𝑥𝑥𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
+ 𝜀𝜀           
A linear analysis is interesting because it facilitates use of the richness of the data – i.e. not just whether 
a patent is renewed but also for how many years – while still not having to rely on the proportional 
hazards assumption as is the case with the Cox survival analysis. Moreover, this analysis allows for direct 
computation of the size of the effect that  patent citations have on the expected lifetime of a patent.  
Furthermore, both logistic and Cox survival analyses use a link function that relies on an exponential 
form. This could affect the form by which the citations correlate with patent renewal. Thus, a linear 
specification would be helpful in showing that the results found in Section 2.2 are not caused by 
modeling choices. Unfortunately, this linearization comes with the assumption that the value of a patent 
and its renewal time are linearly related, which is unlikely, as Section 2.1 explains.  
This equation cannot be estimated using  OLS because patents can only be renewed up to a certain 
point (i.e. 20 years). Therefore, the renewal time variable cannot take values greater than 20 years in 
our data, creating a need to deal with this censoring. Therefore, a Tobit regression analysis is employed, 
which considers censoring at the maximum lifetime of the patent, i.e. 20 years. Because this analysis has 
the same selection issues as logistic analysis, the sample is restricted in the same manner.  
Finally,  a lower bound of the value of a patent can be directly estimated using an interval regression 
analysis where the intervals are determined by the cumulative renewal fees paid by the owner of the 
patent. Here again, censoring needs to be considered for patents that reach their maximum lifetime as 
well as censoring due to limited renewal data. Therefore, the sample restrictions for the binary analysis 
are also employed here.     
The same analyses from Section 2.2 are performed using both the Logit/Tobit and interval regression 
analyses rather than the Cox survival regression. The same curves relating  𝛽𝛽𝑖𝑖 to 𝑖𝑖 are also estimated. 
The results from these estimations are presented in Table 3.  From the evidence of these results, it is 
clear that the logarithmic functional form fits best the relation between the estimated coefficients of the 
dummy 𝛽𝛽𝑖𝑖 and the DOCDB citation score 𝑖𝑖. The analyses provide fit characteristics that are quite similar, 
indicating that the relation between patent citations and private value, as indicated by patent renewal, 
follows the same functional form regardless of the analysis. Therefore, it can be concluded that, of those 
studied, the log-linear form offers the best description of the functional form by which patent citations 
relate to patent value.  
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 USPTO 
    Cox             Logit           Tobit          Interval  
EPO 
    Cox              Logit            Tobit          Interval  
Linear 0.54 0.57 0.57 0.53 0.78 0.76 0.81 0.80 
Quadratic 0.76 0.80 0.80 0.75 0.88 0.88 0.90 0.90 
Log-linear 0.86 0.91 0.91 0.87 0.93 0.94 0.94 0.94 
Table 3: R2 of the different fits that relate 𝛽𝛽𝑖𝑖 to 𝑖𝑖  for each analysis at each patent office. It should be noted that the Logit, Tobit and interval 
analyses for EPO were performed on a smaller sample and are thus not fully comparable with the Cox survival regressions. 
2.4 The relation between patent value and patent citations 
The results obtained from the main analysis in Section 2.2 and from the robustness analyses are 
informative in establishing the functional form that relates patent citations to patent value. However, 
the fits themselves may, in addition, explain the relevance of patent citations in more economic terms. 
Hence, the fits are presented with an interpretation of their estimated effect in Table 4.  
The estimated effect of each additional patent citation is harder to estimate using the log-linear form. 
Therefore, the effects are given for patents that have double the number of patent citations than a 
patent with similar scores on the control variables. Given a log-linear fit of 𝛽𝛽𝑖𝑖 = 𝑎𝑎 + 𝑏𝑏 ln(𝑐𝑐 + 𝑖𝑖),  this 
translates as 𝑏𝑏ln (2). It should be noted that having double the citations should be interpreted using the 
offset, i.e. the 𝑐𝑐 parameter in the log-linear fit.  Therefore ,‘doubling’ the citations for an uncited EPO 
patent means adding 14 citations in the case of the Tobit regression.     
 
Office Analysis Log-linear fit relating  Estimated comparative effect of having double 
the number of citations than a comparable patent  
USPTO 
Cox  𝛽𝛽𝑖𝑖 = 0.33 − 0.32 ln(1.43 + 𝑖𝑖) Decreased abandonment hazard of 0.22 
Logit 𝛽𝛽𝑖𝑖 = −0.43 + 0.48 ln(1.12 + 𝑖𝑖) Increased odds of full renewal of 0.33 
Tobit 𝛽𝛽𝑖𝑖 = −3.15 + 2.86 ln(1.44 + 𝑖𝑖) Increased renewal time of 0.99 years 
Interval 𝛽𝛽𝑖𝑖 = −1366 + 1642 ln(1.00 + 𝑖𝑖) Increased value of $1137.95 
EPO 
Cox  𝛽𝛽𝑖𝑖 = 1.27 − 0.55 ln(10.80 + 𝑖𝑖) Decreased abandonment hazard of 0.38 
Logit 𝛽𝛽𝑖𝑖 = −1.49 + 0.80 ln(6.49 + 𝑖𝑖) Increased full renewal odds of 0.56 
Tobit 𝛽𝛽𝑖𝑖 = −8.64 + 3.32 ln(14.05 + 𝑖𝑖) Increased renewal time by 2.30 years 
Interval 𝛽𝛽𝑖𝑖 = −12738 + 5021 ln(13.67 + 𝑖𝑖) Increased value of €3480.62 
Table 4: Fits and economic interpretation of the analyses relating patent citations to patent value  
The results listed in Table 4 show that the estimated effect size of having been cited more than a 
comparable patent is substantial. Estimates show that patent citations confer value that can be 
measured in years of additional patent life and a value increase of thousands of euros/dollars. It should 
be noted that patent renewal analyses intrinsically estimate minimum values of patent value. Therefore, 
the value added by doubling patent citations may very well be much higher. Interestingly, with regard to 
USPTO patents, this value appears lower than for EPO patents, both in renewal time and patent value. 
However, the latter is in part due to the lower maintenance fees at the USPTO.    
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3 Applying the functional form to an econometric analysis 
3.1 Introduction 
The previous section established a log-linear relation between patent citations and patent value. Sets of 
patents, i.e. patent portfolios, can also be evaluated using patent citations. The value of a patent 
portfolio is generally estimated by counting the number of times any patent in the portfolio has been 
referenced. This practice could be justified on the assumption that the value of a patent portfolio is 
equal to the sum of the value of its members. The logical conclusion is that, when the value of individual 
patents is calculated differently, this should have repercussions for the estimation of the value of patent 
portfolios. Therefore, in this paper, a new method that relies on the found log-linear relation is 
introduced.  
In this log-linear method, the value of a patent portfolio is derived by first computing a log-transformed 
value for each patent and then computing the sum of these log-transformed values. Because this 
method better models the relation between patent citations and patent value, it could prove superior to 
the normal linear method of estimating the value of a patent portfolio, i.e. simply computing the sum of 
individual patent citations.  
A superior method of calculating the value of the patent portfolio would enhance understanding of firm 
innovative performance, an often-used metric in innovation research. To evaluate the log-linear 
method, a patent portfolio analysis is presented using both the traditional way of computing the value 
of a patent portfolio and the proposed log-linear method. For this endeavor,  an adapted analysis of Hall 
et al.  (2005) is presented, which relates Tobin’s Q, (𝑄𝑄) to stocks of R&D, patents and patent citations. 
3.2 Methods and Data 
In this chapter, the analysis adapted from Hall et al. (2005) is used to assess which method of  evaluating 
patent portfolios better explains firm performance: the common linear method or the log-linear method 
that models a log-linear relation between patent citations and patent value. The analysis of Hall et al.  
(2005) models Tobin’s Q as a function of the relative knowledge stock of the firm. This stock is then 
approximated using the ratio between the R&D stock and the assets of the firm as well as other ratios 
involving the R&D stock, the patent stock, and the patent citation stock. Controls for year as well as the 
firm will also be included in the analysis. Therefore, the following equation is estimated:      
ln𝑄𝑄𝑖𝑖𝑐𝑐 =𝐷𝐷𝑖𝑖 + 𝐷𝐷𝑐𝑐 + ln �1 + 𝛽𝛽1 𝑅𝑅&𝐷𝐷𝑖𝑖𝑐𝑐𝐴𝐴𝑖𝑖𝑐𝑐 + 𝛽𝛽2 𝑃𝑃𝐴𝐴𝑃𝑃𝑖𝑖𝑐𝑐𝑅𝑅&𝐷𝐷𝑖𝑖𝑐𝑐 + 𝛽𝛽3 𝐷𝐷𝐶𝐶𝑃𝑃𝐶𝐶𝐶𝐶𝑖𝑖𝑐𝑐𝑃𝑃𝐴𝐴𝑃𝑃𝑖𝑖𝑐𝑐 + 𝐷𝐷𝑅𝑅&𝐷𝐷𝑖𝑖𝑖𝑖=0� + 𝜀𝜀𝑖𝑖𝑐𝑐  
Here 𝐷𝐷𝑖𝑖 and 𝐷𝐷𝑐𝑐 denote constants of firm 𝑖𝑖 and time 𝑡𝑡 while 𝐴𝐴𝑖𝑖𝑐𝑐 denotes the total assets. 𝑅𝑅&𝐷𝐷𝑖𝑖𝑐𝑐, 𝑃𝑃𝐴𝐴𝑃𝑃𝑖𝑖𝑐𝑐 
and 𝐷𝐷𝐶𝐶𝑃𝑃𝐶𝐶𝐶𝐶𝑖𝑖𝑐𝑐 denote respectively the R&D, patent and citations depreciated stock. 𝐷𝐷𝑅𝑅&𝐷𝐷𝑖𝑖𝑖𝑖=0  denotes a 
dummy for firms with no reported R&D expenditures at time 𝑡𝑡. When this dummy is equal to 1, the ratio 
𝑃𝑃𝑃𝑃𝑃𝑃𝑖𝑖𝑖𝑖
𝑅𝑅&𝐷𝐷𝑖𝑖𝑖𝑖 is set to 0 if the R&D stock, 𝑅𝑅&𝐷𝐷𝑖𝑖𝑐𝑐, is equal to 0. There are also cases for which the patent stock is 
equal to 0; these are not used in the analysis. Finally, 𝜀𝜀𝑖𝑖𝑐𝑐 represents a random error.  
The non-linear analysis that follows from equation 4 is presented along with a linearized version, which 
assumes ln (1 + 𝑥𝑥) ≈ 𝑥𝑥. This linear analysis has the benefit of facilitating a fixed effects approach, which 
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is not possible with the non-linear analysis, as noted in Hall et al.  (2005). In the non-linear analyses, 𝐷𝐷𝑖𝑖 is 
approximated using sector dummies of the Standard Industry Classification (SIC).    
For this analysis, USPTO applications (since the sample mainly concerns US firms) combined with DOCDB 
citation information are matched to a random sample of patenting firms with at least 100 patents listed 
in PATSTAT, and that are listed in the Compustat database.  For the resulting sample of 1092 firms, 
financial data is considered from the years between 1981 and 2005. In this paper, citation stock 
increases are modeled using a linear model as well as the log-linear model previously specified.  
The sample was constructed as follows: only firms that have a continuous presence in at least two 
periods in the dataset were used. Moreover, in order to accurately compare patenting firms, only 
observations of firms that have a non-zero patent stock – i.e. observations of firms that have at least 
one patent in the current or any previous period – are used.3 Finally,  Tobin’s Q was not known for all 
observations in the resulting dataset, leading to the removal of 1890 observations.   
The R&D stock was initialized as the R&D expenditure for the first year in which a firm enters the sample 
divided by 0.23, in a procedure similar to Hall  (1990) and Hall et al. (2005). The patent stock and the 
citation stocks are not initialized because the full patenting activity of all firms is observed for 30 years 
prior to the first year of the sample using the EPO PATSTAT database. Finally, all stocks are depreciated 
by 15% each year, in line with Hall et al.  (2005).  The descriptive statistics of the sample are detailed in 
Table 5. 
Variable Description Number of 
Observations 
Mean Standard 
Deviation 
Min Max 
Ln (Tobin's Q) Natural log of market value divided by total assets    13044 0.39 0.78 -6.23 4.63 
Year Book year of the firm, application year of the patents 13044 1995 7.39 1980 2005 
R&D stock  The current stock of R&D expenses ($M) 13044 631 2091 0.00 29814 
Total Assets  The total assets of the firm ($M) 13044 4841 24430 0.04 658800 
D(R&D=0) Dummy to indicate no R&D expenses in that year 13044 0.116 0.32 0 1 
Patent stock The current stock of USPTO patents 13044 239 843 0.00 14649 
Citation stock  
�𝑪𝑪𝑪𝑪𝑪𝑪 
The current citation stock,  
calculated using the linear method 13044 4402 15156 0.02 226776 
Citation stock 
�𝐥𝐥𝐥𝐥 (𝟏𝟏 + 𝑪𝑪𝑪𝑪𝑪𝑪) The current citation stock,  calculated using the log-linear method  13044 579 2038 0.01 31932 
Table 5: Descriptive statistics of the variables used in the horse race regressions. Below each citation stock is listed the formula used to create it, 
where 𝐷𝐷𝐶𝐶𝑃𝑃 refers to the citation score of an individual patent. R&D stock and total assets are adjusted for inflation using USBLS(2016) data 
(1983=100). All stocks are calculated with a 15% depreciation rate.   
3.3 Results 
The results of the fixed effects linear models are shown in Table 6. The increase in R2 shows that citation 
indicators using the log-linear transformation perform better – with an increase of 3.4% in explained 
variance – at explaining log Tobin’s Q than the citation indicators without the use of the logarithmic 
transformation. This represents a substantial increase of 70% in added explained variance by introducing 
                                                          
3 A comparative analysis that included observations for firms with no patent stock as well as a dummy  controlling 
for this occurrence yielded very similar results to the analyses presented in this paper.  
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a citation indicator to explain company performance. Therefore, this analysis shows the potential of 
applying the log transformation to portfolio analysis, while simultaneously providing external validity to 
the findings in Chapter 2.  
The non-linear analysis of Hall et al.  (2005) was also performed: see analyses 4, 5 and 6. Applying their 
analysis to this paper’s sample produces very similar results, with one exception: the ratio of patent 
stock over R&D stock, representing patenting efficiency, is negative. The likely cause is the inclusion of 
several firms for which R&D expenditure is not listed in the COMPUSTAT database and for which this 
ratio is recorded as 0. Analyses excluding these firms produce a positive coefficient for this ratio. The 
linear and the log-linear specifications of the citation stock perform very similarly in the non-linear 
analysis: there is only a difference of 0.007 in their 𝑅𝑅2. Using the log-linear form only adds 2.9% in added 
explained variance. 
Including firm dummies instead of SIC dummies give very similar results, as can be seen from analyses 
7,8 and 9. However, here the linear specification performs slightly (0.006) better. This represents a 
decrease of 17% in explained variance when using the log-linear method as opposed to the classical 
method. This analysis, therefore, demonstrates that that the log-linear method of citation counting does 
not always deliver improvement, but it produces adequate results nonetheless.    
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 (1) (2) (3) (4) (5) (6) (7) (8) (9) 
 Fixed effects Fixed effects Fixed effects Non-linear Non-linear Non-linear Non-linear Non-linear Non-linear 
R&Da/ Total assets 0.0154** 0.0156** 0.0156** 0.100** 0.145** 0.237* 0.0370 0.0439 0.0558 
 (0.00553) (0.00550) (0.00546) (0.0343) (0.0463) (0.0922) (0.0271) (0.0316) (0.0406) 
          
Patentsa/R&Da -0.000883** -0.000743 -0.000781* -0.000456*** -0.000545** -0.00114*** -0.000509*** -0.000544** -0.000723*** 
 (0.000297) (0.000387) (0.000324) (0.000110) (0.000181) (0.000222) (0.000133) (0.000192) (0.000180) 
          
D(R&Dit=0) 0.0880 0.0811 0.0767 0.0122 0.0422 0.0620 0.0893 0.0960 0.127 
 (0.0668) (0.0666) (0.0652) (0.0519) (0.0588) (0.119) (0.0775) (0.0825) (0.105) 
          
Citationsa/Patentsa  0.00213***   0.0119***   0.00457**  
�𝐂𝐂𝐂𝐂𝐂𝐂  (0.000579)   (0.00181)   (0.00155)  
          
Citationsa/Patentsa   0.124***   0.630***   0.159* 
�𝐥𝐥𝐥𝐥 (𝟏𝟏 + 𝐂𝐂𝐂𝐂𝐂𝐂)   (0.0308)   (0.152)   (0.0642) 
          
Constant 0.258*** 0.204*** -0.0601 0.390*** 0.0954 -0.540** -0.324*** -0.355*** -0.567*** 
 (0.0302) (0.0333) (0.0834) (0.117) (0.122) (0.201) (0.0153) (0.0177) (0.0877) 
Year dummies Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Firm controls Yes Yes Yes No No No Yes Yes Yes 
SIC dummies No No No Yes Yes Yes No No No 
N 13044 13044 13044 13044 13044 13044 13044 13044 13044 
Nr. Firms 1092 1092 1092 1092 1092 1092 1092 1092 1092 
Nr. SIC 214 214 214 214 214 214 214 214 214 
R² 0.075 0.125 0.160 0.4666 0.4905 0.4912 0.7028 0.7052 0.7046 
Table 6: Horse race regressions explaining Ln(Tobin’s Q). Variables with a  represent stocks with a 15% depreciation rate. Below each citation stock is listed the formula used to create it, where 𝐷𝐷𝐶𝐶𝑃𝑃 
refers to the citation score of an individual patent. Cluster-robust standard errors are reported in parentheses and asterisks indicate statistical significance with: * p < 0.05, ** p < 0.01, *** p < 0.001.  
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4 Conclusion 
The main result of this paper is that patent citations display a log-linear relation with patent value. 
Therefore, researchers are advised to take this relation into consideration when using patent citations to 
approximate patent value. The fits obtained from the renewal analysis show that patents with double 
the number of citations than comparable patents have an increased value of $1137.95 in the case of 
USPTO patents and €3480.62 in the case of EPO patents. The results of the firm analysis indicate that, at 
least in some economic models, it may be better to first apply a log transformation to the citation count 
of an individual patent before computing the sum. Doing so may yield an improvement of up to 70% in 
added explained variance. Yet, in another analysis, the classical way of calculating patent citations has 
proved slightly superior. For that reason, the log-linear transformation should be used with caution.  
When using a logarithmic functional form, the explanatory power of the citation indicator improves. Yet, 
much unexplained variance remains. Therefore, we should continue to keep in mind the limited ability 
of patent citations to approximate patent value. Moreover, the found functional form reflects the 
relation between patent citations and private value, but it may not hold true for other value constructs 
such as the social value and (knowledge) impact of a patent. Hence, researchers should be careful when 
applying the findings of this paper to approximate other constructs of patent value. 
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